KeyBanc Starts Bemis (BMS) at Hold; Defensive Stock, But Trading Above Historical Averages
Get Alerts BMS Hot Sheet
Price: $57.25 --0%
Rating Summary:
2 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
KeyBanc initiates coverage on Bemis (NYSE: BMS) with a Hold.
Analyst, Adam J. Josephson, said, "We are initiating coverage of Bemis with a HOLD rating, as we find the steady free cash flow characteristics of this business (and the resulting 3.2% dividend yield) attractive but are concerned about a number of fundamental challenges: weak volume trends in the U.S. packaged food industry; weak volume trends in the high margin piece of its Pressure Sensitive Materials business; and its exposure to resin prices, which in recent years have become increasingly volatile...The stock is trading above its historical average multiples on our estimates."
For an analyst ratings summary and ratings history on Bemis click here. For more ratings news on Bemis click here.
Shares of Bemis closed at $30.92 yesterday.
Analyst, Adam J. Josephson, said, "We are initiating coverage of Bemis with a HOLD rating, as we find the steady free cash flow characteristics of this business (and the resulting 3.2% dividend yield) attractive but are concerned about a number of fundamental challenges: weak volume trends in the U.S. packaged food industry; weak volume trends in the high margin piece of its Pressure Sensitive Materials business; and its exposure to resin prices, which in recent years have become increasingly volatile...The stock is trading above its historical average multiples on our estimates."
For an analyst ratings summary and ratings history on Bemis click here. For more ratings news on Bemis click here.
Shares of Bemis closed at $30.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Wells Fargo Starts Vivmark Residential (VMRK) at Overweight, 'Setting the mark for growth'
- BNP Paribas Exane Starts NIQ Global Intelligence Plc (NIQ) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
KeyBanc, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share